Gilead Sciences stock: earnings on October 29, 2026, slightly lower pre-market
Published on 10/26/2026 at 07:48 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWSEarnings date and market context
- Gilead has scheduled its third-quarter 2026 earnings viewing for October 29, 2026.
- In 2026, Gilead's pipeline spans virology, oncology and inflammation.
- Gilead Sciences stock trades pre-market at EUR 139.08 at 7:47 a.m. CET at Lang & Schwarz on October 26, 2026, 0.67 percent below the Xetra close of October 23, 2026.
Gilead Sciences says its third-quarter 2026 earnings viewing is scheduled for October 29, 2026, at 4:30 p.m. ET. Gilead Sciences stock trades pre-market at EUR 139.08 at 7:47 a.m. CET at Lang & Schwarz on October 26, 2026, 0.67 percent below the Xetra close of October 23, 2026 (EUR 140.02).
Gilead earnings date
The company’s website lists the October 29, 2026, event as “Gilead Sciences Q3 2026 Earnings.” The scheduled viewing time is 4:30 p.m. ET, according to Gilead.
Ahead of the Xetra open
The indication is EUR -0.94 versus the Xetra close of October 23, 2026. The further course from the Xetra open at 9:00 a.m. CET/CEST is shown by the continuously updated real-time quote of Gilead Sciences stock.
Science and the coming week
Gilead develops and supplies medicines across virology, oncology and inflammation for global healthcare markets, according to its website. The company’s next scheduled date is the third-quarter earnings viewing on October 29, 2026. Market context: Market report S&P 500.
